Sepsis Indicators Parameters Provided by Sysmex Automated Hematology Analyzers: Streamlining Diagnosis and Therapy in Critically ill Patients
Early diagnosis of sepsis is a challenge for physicians because the success or failure of patient evolution is related to the fast recognition of the syndrome presence and the prompt therapeutic approach.
Multiparameter flow cytometry has become an integral tool in the work-up of abnormal WBC findings, allowing for rapid and accurate identification of abnormal cell populations, cell lineage assignment and assessment of clonality. This presentation will discuss a series of cases that demonstrate the utility of flow cytometry in the diagnostic workup of hematologic disorders presenting with abnormal WBC differential and incorporation of relevant criteria from the revised WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.
Sysmex XN-L analyzers are compact and suitable for laboratories that process small and medium volume samples. Some evaluations published in the literature reveal similar performance of the XN-L line when compared to XN analyzers. Learn about the characteristics of this Sysmex innovation and how it can be implement in your laboratory routine.
These are transformative times in the healthcare industry and especially for the clinical laboratory. Significant reimbursement
cuts and payment reform linked to quality measures are driving a new approach to laboratory testing. Laboratorians faced with a
changing business model and growing staff shortages are increasingly being asked to justify the value the laboratory provides.
Automation in urinalysis is a topic that has been gaining ground in the laboratory medicine environment. More and more technological resources are being sought for routine optimization, especially when we talk about large clinical analysis laboratories. Automated Urinalysis Systems, such as Sysmex’s UN-3000 solution, provide analytical workflow improvement as they enable more efficient analysis of a large number of samples. This allows the professionals responsible for the analysis to devote most of their time to samples that actually have clinically relevant changes while those samples without alterations can be safely released within a short time.